COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,086 Articles (22,658 medRxiv, 8,428 bioRxiv)

Most recent first Previous |  Page 1062: Articles 10611-10620  | Next

Incidence rates and symptomatology of community infections with SARS-CoV-2 in children and parents: The CoKids longitudinal household study
de Hoog, M., Post-Sluiter, J., Westerhof, I., Fouri, E., Heuvelman, V., Boom, T., Euser, S. M., Badoux, P., Reusken, C., Bont, L., Sanders, E., Jaddoe, V., Herpers, B., Eggink, D., Wildenbeest, J., Duijts, L., Houten, M. v.
10.1101/2021.12.10.21267600 — Posted: 2021-12-11
Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum
Dejnirattisai, W., Shaw, R. H., Supasa, P., Liu, C., Stuart, A. S. V., Pollard, A. J., Liu, X., Lambe, T., Crook, D., Stuart, D. I., Mongkolsapaya, J., Nguyen-Van-Tam, J. S., Snape, M. D., Screaton, G. R., Com-COV2 Study Group
10.1101/2021.12.10.21267534 — Posted: 2021-12-11 Discussion: Onsite
SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
Roessler, A., Riepler, L., Bante, D., von Laer, D., Kimpel, J.
10.1101/2021.12.08.21267491 — Posted: 2021-12-11
Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection
Hernandez, M. M., Riollano-Cruz, M., Boyle, M. C., Banu, R., Shrestha, P., Gray, B., Cao, L., Chen, F., Shi, H., Paniz-Perez, D. E., Paniz-Perez, P. A., Rishi, A. L., Dubinsky, J., Dubinsky, D., Dubinsky, O., Baine, S., Baine, L., Arinsburg, S., Baine, I., Ramirez, J. D., Cordon-Cardo, C., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.12.09.21267539 — Posted: 2021-12-11
Accuracy and usability of saliva and nasal rapid antigen self-testing for detection of SARS-CoV-2 infection in the general population: a head-to-head comparison
Schuit, E., Venekamp, R. P., Veldhuijzen, I. K., van den Bijllaardt, W., Pas, S. D., Stohr, J. J. J. J. M., Lodder, E. B., Hellwich, M., Molenkamp, R., Igloi, Z., Wijers, C., Vroom, I. H., Nagel-Imming, C. R. S., Han, W. G. H., Kluytmans, J. A. J., van den Hof, S., Van de Wijgert, J. H. H. M., Moons, K. G. M.
10.1101/2021.12.08.21267452 — Posted: 2021-12-11 Discussion: Onsite
Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads
Matsui, Y., Li, L., Prahl, M., Cassidy, A. G., Ozarslan, N., Golan, Y., Gonzalez, V. J., Lin, C. Y., Jigmeddagva, U., Chidboy, M. A., Montano, M., Taha, T. Y., Khalid, M. M., Sreekumar, B., Hayashi, J. M., Chen, P.-Y., Kumar, G. R., Warrier, L., Wu, A. H. B., Song, D., Jegatheesan, P., Rai, D. S., Govindaswami, B., Needens, J., Rincon, M., Myatt, L., Asiodu, I. V., Flaherman, V. J., Afshar, Y., Jacoby, V. L., Murtha, A. P., Robinson, J. F., Ott, M., Greene, W. C., Gaw, S. L.
10.1101/2021.12.09.21267557 — Posted: 2021-12-11
Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England
Ladhani, S. N., Ireland, G., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S., Garstang, J., Brent, A. J., Brent, B., Aiano, F., Amin-Chowdhury, Z., Kall, M., Borrow, R., Linley, E., Zambon, M., Poh, J., Warrener, L., Lackenby, A., Ellis, J., Amirthalingam, G., Brown, K. E., Ramsay, M. E.
10.1101/2021.12.10.21267583 — Posted: 2021-12-11
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction
Rouhani, S. J., Trujillo, J. A., Pyzer, A. R., Yu, J., Fessler, J. L., Cabanov, A., Higgs, E. F., Cron, K. R., Zha, Y., Lu, Y., Bloodworth, J. C., Abasiyanik, M. F., Okrah, S., Flood, B. A., Hatogai, K., Leung, M. Y., Pezeshk, A., Kozloff, L., Reschke, R., Strohbehn, G. W., Chervin, C. S., Kumar, M., Schrantz, S., Madariaga, M. L., Beavis, K. G., Yeo, K.-T. J., Sweis, R., Segal, J., Tay, S., Izumchenko, E., Mueller, J., Chen, L. S., Gajewski, T. F.
10.1101/2021.12.09.21266492 — Posted: 2021-12-11
Analytical evaluation of thirty-two SARS-CoV-2 lateral flow antigen tests demonstrates sensitivity remains with the SARS-CoV-2 Gamma lineage.
Kontogianni, N., Bengey, D., Wooding, D., Buist, K., Greenland-Bews, C., Williams, C. T., de Vos, M., Escadafal, C., Adams, E. R., Edwards, T., Cubas Atienzar, A. I.
10.1101/2021.12.08.21267455 — Posted: 2021-12-11
Predicted Symptomatic Effectiveness of Pfizer-BioNTech BNT162b2 Vaccine Against Omicron Variant of SARS-CoV-2
Volkov, O.
10.1101/2021.12.09.21267556 — Posted: 2021-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).